000 | 01413 a2200421 4500 | ||
---|---|---|---|
005 | 20250511202959.0 | ||
264 | 0 | _c19920122 | |
008 | 199201s 0 0 eng d | ||
022 | _a0040-6376 | ||
024 | 7 |
_a10.1136/thx.46.10.706 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWiselka, M J | |
245 | 0 | 0 |
_aProphylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. _h[electronic resource] |
260 |
_bThorax _cOct 1991 |
||
300 |
_a706-11 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Intranasal |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAsthma _xcomplications |
650 | 0 | 4 |
_aBronchitis _xcomplications |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Type I _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aRespiratory Tract Infections _xcomplications |
650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
700 | 1 | _aNicholson, K G | |
700 | 1 | _aKent, J | |
700 | 1 | _aCookson, J B | |
700 | 1 | _aTyrrell, D A | |
773 | 0 |
_tThorax _gvol. 46 _gno. 10 _gp. 706-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/thx.46.10.706 _zAvailable from publisher's website |
999 |
_c1756413 _d1756413 |